Dermatological Inflammation

How AAGP® could help break through current treatment barriers

Millions of people suffer with inflamed, uncomfortable skin. In fact, more than 1 in 4 Americans (26%) have at least one skin disease, according to the American Academy of Dermatology.

Inflammatory skin conditions are the most common dermatological issue, but researchers are exploring how AAGP© can help.


The causes of dermatological inflammation

There are many causes that can contribute to dermatological inflammation. Infection, allergens, or sun exposure can trigger rapid, acute inflammation, while chronic inflammation may be caused by immune system dysfunctions or even imbalances in the gut microbiome.

Aging, environmental factors, genetics, and trauma each can trigger an inflammatory response, posing a threat to skin cells. And diseases such as diabetes can cause chronic, non-healing wounds or ulcers, in which the damaged skin is trapped in a cycle of inflammation, leading to pain, infection, and even amputation.

The symptoms of dermatological inflammation

Depending on the cause, severity, and location of the affected area, skin inflammation can present a number of different symptoms:

  • Burning
  • Stinging
  • Itching
  • Redness
  • Heat or warmth in affected area
  • Scales
  • Rashes
  • Blisters or raised bumps
  • Cracks
  • Bleeding
  • Ulcers
Microscope image

Treatments for dermatological inflammation

Treatments for dermatological inflammation vary depending on cause. Currently, common treatments include medications such as N-SAIDs (non-steroidal anti-inflammatory drugs) or corticosteroids. Other treatments include antibiotics, antifungals, or antihistamines, if the cause is determined to be an infection or allergen.

AAGP® as a potential solution

A synthetic solution like AAGP© could make a huge difference to people suffering from skin inflammation.

Imagine a molecule that can promote the acute survival of skin cells to aid in healing — after the fact. AAGP, with its anti-aging properties, has the potential to treat inflammatory skin conditions by actually healing cells that have suffered inflammation and damage.

We’re just scratching the surface of what this revolutionary glycopeptide can do. Its ability to promote cell survivability shows promise for its ability to repair damaged cells, and its synthetic nature could help put the cost of therapies within reach for many.

Treating inflammatory skin concerns with AAGP© could make relief more accessible and more affordable for more people, easing the burden of skin disease for millions.

ProtoKinetix research and clinical trials

Find out what weve learned so far about the impact AAGP® could have in the field of dermatology.

Market potential for dermatological inflammation

The global anti-aging cosmetics market is expected to grow from $39 billion in 2018 to $60 billion by 2026, according to Fortune Business Insights. Demand will be boosted by the increasing prevalence of skin-related problems in conjunction with technological advancements that make these products more powerfully effective.

Meanwhile, forecasts by Visiongain estimate the market for dermatology drugs to grow from $26 billion in 2018 to $36 billion by 2024. An increase in prevalence of skin disease is a major driver of this growth, but so is an increasing awareness of available treatments.

There is an exciting opportunity here to be part of our journey to provide relief and treatment to millions of people hungry for a solution.

2018 Market Revenue:

$26 Billion

2024 Market Forecast:

$36 Billion


Support our research into healing skin inflammation, while also supporting your financial future. Contact your broker or reach out to our team at ProtoKinetix to learn about potential investment options.

  • This field is for validation purposes and should be left unchanged.